TxID Early Career Network (@txid_fellows) 's Twitter Profile
TxID Early Career Network

@txid_fellows

Virtual networking for #TxID trainees | #TxIDChat 🧫 🦠 | Events | Jobs | Research | #MedEd | Moderated: @GorslineChelsea + @CourtHarrisMD + @rebecca_kumar

ID: 1364700199403323406

calendar_today24-02-2021 22:14:55

987 Tweet

2,2K Followers

388 Following

transplantid.net (@transplantidnet) 's Twitter Profile Photo

Welcome new #IDfellows TxID Early Career Network IDFellowsCup! Did you know that transplantid.net stays up to date with the newest IDSA IDSA Medical Education Community of Practice #IDSAGuidelines? Links to many of them under "GUIDELINES" transplantid.net/?guidelines=4D…

Joanna Schaenman MD PhD (@jschaenman) 's Twitter Profile Photo

Attention #IDFellows : the Division of Infectious Diseases at UCLA is seeking candidates for a 1-yr career development position in Transplant Infectious Diseases during academic year 2025-2026. Please see recruit.apo.ucla.edu/JPF09516 for details ! Infectious Disease Fellows Network #IDTwitter #IDMedEd

Luis Ostrosky, MD, FIDSA (@drluiso) 's Twitter Profile Photo

One of the most interesting, and not yet disclosed, parts of the Matamoros #fusarium #outbreak #TxID patients exposed through donor. No infections with #prophylaxis onlinelibrary.wiley.com/doi/abs/10.111…

John Baddley (@jobadd) 's Twitter Profile Photo

A fun project from which I learned a lot. Thanks to ⁦Katya Prakash⁩ and the team for all of the work. Minimizing risk while maximizing opportunity: The infectious disease organ offer process survey onlinelibrary.wiley.com/doi/10.1111/ti…

Ilan Schwartz MD PhD (@germhuntermd) 's Twitter Profile Photo

Consensus Definitions of Cytomegalovirus (#CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum #TxID academic.oup.com/cid/advance-ar…

Consensus Definitions of Cytomegalovirus (#CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

#TxID 

academic.oup.com/cid/advance-ar…
transplantid.net (@transplantidnet) 's Twitter Profile Photo

🚨NEWS FLASH!🚨 Due to popular demand, transplantid.net now has a new JOURNAL CLUB section This month Nicolas Barros & Pascalis Vergidis MD, MSc discuss 200-day letermovir prophylaxis in HSCT! The Lancet Haematology ASTCT The EBMT Their excellent discussion at transplantid.net/MY26WACL

🚨NEWS FLASH!🚨
Due to popular demand, transplantid.net now has a new JOURNAL CLUB section

This month <a href="/NicoBarrosID/">Nicolas Barros</a> &amp; <a href="/pascalisID/">Pascalis Vergidis MD, MSc</a> discuss 200-day letermovir prophylaxis in HSCT! <a href="/TheLancetHaem/">The Lancet Haematology</a> <a href="/ASTCT/">ASTCT</a> <a href="/TheEBMT/">The EBMT</a> 

Their excellent discussion at transplantid.net/MY26WACL
Chelsea Gorsline MD (@gorslinechelsea) 's Twitter Profile Photo

Much needed guidance for infxn + CAR-T Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management after Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies

Jessica Little, MD (@jessicalittlemd) 's Twitter Profile Photo

Bispecific antibody therapy is a novel immunotherapy 💊 for hematologic malignancies, but opportunistic infections 🦠remain a serious concern. Here we report the first case of disseminated MAC infection in a patient on BsAb tx Ben Teh Eddie Cliff academic.oup.com/ofid/advance-a…

Apu Akkad (@apuakkad1) 's Twitter Profile Photo

#MedTwitter Clinical pearl: In a patient with neutropenic fever, if an infectious source is identified, no need to continue empiric treatment. Treat the known infection with optimal and targeted therapy. TxID Early Career Network IDSA Medical Education Community of Practice

Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@absteward) 's Twitter Profile Photo

Mind blowing 🤯 A 🆕️⚡️⚡️ retrospective matched cohort study Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients #IDXposts onlinelibrary.wiley.com/doi/full/10.11…

Mind blowing 🤯
A 🆕️⚡️⚡️ retrospective matched cohort study
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients 
#IDXposts
onlinelibrary.wiley.com/doi/full/10.11…
Tobias Hohl MD, PhD (@tmhohl71) 's Twitter Profile Photo

We are recruiting an ID physician to join our clinical team Memorial Sloan Kettering Cancer Center. The ID service is a wonderful community for clinicians, educators, and investigators, or a mix of all three + has ID fellows. Please RT and apply. #TransplantID #IDJobs healthecareers.com/job/faculty-po…

Michael Ison, MD MS (@michaelgisonmd) 's Twitter Profile Photo

Looking forward to our next TTS TID Section-TransplantID Journal CPC! Another challenging case presenting as abdominal pain in a SOT recipient. Thursday October 10 at 7am Eastern/12pm CET/9pm Sydney. Register Today: tracking.tts.org/click?u=https%…

Looking forward to our next TTS TID Section-<a href="/TheTxIDjournal/">TransplantID Journal</a> CPC!  

Another challenging case presenting as abdominal pain in a SOT recipient.  Thursday October 10 at 7am Eastern/12pm CET/9pm Sydney.

Register Today:  tracking.tts.org/click?u=https%…
Michael Ison, MD MS (@michaelgisonmd) 's Twitter Profile Photo

🚨 CRITICAL READ 🚨 If you do research in Transplant ID, this paper is a MUST read. From Christine Durand and the The Transplant Research Center a brilliant blueprint in how to build a successful transplant research center. From TransplantID Journal onlinelibrary.wiley.com/doi/10.1111/ti…